Please Wait...

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Congress - Berlin, Germany

ECTRIMS Annual Congress
October 10, 2018 - 1:00am (EDT) to October 12, 2018 - 1:00am (EDT)

Berlin, Germany

Latest advances in artificial intelligence (AI) in multiple sclerosis (MS) segmentation. "Deep Learning-Based Automated MS T2 Lesion Segmentation." Bioclinica's Director of Neuroscience, Luc Bracoud, will present our latest image analysis developments applied to MS during the October 12th poster session at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Congress in Berlin. View the ECTRIMS program for session details: P1138 - Deep-learning based automated MS T2 lesion segmentation, presented by Luc Bracoud, Director of Neuroscience, Bioclinica.

To learn about the application of AI in MS and other recent developments and how Bioclinica's domain experts can support your MS trials, submit a Contact Us form and we will direct your request to Luc Bracoud and Dr. Joyce Suhy.

Visit event website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Sponsor insights on site and patient payments: https://t.co/VNiwaeDNWi
Bioclinica (3 hours ago)
ICYMI: Catch up on FDA Draft Guidance on BP Response in clinical trials https://t.co/uJp90qqQJx https://t.co/2dNI4AvXYU
Bioclinica (Yesterday)
RT @Xtalks: Detection and Monitoring in #FattyLiver #ClinicalTrials: The Role of Medical Imaging NASH is characterized by the presence of a…
Bioclinica (Yesterday)
RT @FCR_News_Today: CROs Deliver Shorter Cycle Times, Says New Tufts Report. #ClinicalTrial #ClinicalResearch https://t.co/PWe7qIGewt @…
Bioclinica (4 days ago)
RT @EMA_News: Today we are saying ‘hallo’ to our new home. Thank you, #Amsterdam and the Netherlands, for the warm welcome! https://t.co/hi…
Bioclinica (4 days ago)
RT @ACROhealth: How are patients finding #clinicaltrials? @Microsoft thinks chat bots could be the next recruitment frontier: #medtech #cli…
Bioclinica (4 days ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box